Seton Placement ( DrugBank: - )
1 disease
| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 96 | クローン病 | 2 |
96. クローン病
臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04847739 (ClinicalTrials.gov) | September 13, 2021 | 1/4/2021 | Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II) | Seeded Cells on Matrix Plug Treating Crohn's Perianal Fistulas (STOMP-II) | Perianal Fistula;Crohn's Disease | Procedure: Seton Placement;Drug: AVB-114 | Avobis Bio, LLC | Alimentiv Inc. | Recruiting | 18 Years | 70 Years | All | 60 | Phase 2 | United States |
| 2 | NCT00517296 (ClinicalTrials.gov) | January 2008 | 15/8/2007 | Endoscopic Ultrasound (EUS) Guided Treatment With Humira for Crohn's Perianal Fistulas | EUS Guided Treatment With Humira for Crohn's Perianal Fistulas | Crohn Disease;Rectal Fistula | Procedure: EUA with seton placement if necessary;Drug: adalimumab;Procedure: EUS | Vanderbilt University Medical Center | NULL | Completed | 18 Years | N/A | All | 21 | Phase 4 | United States |